These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6295856)

  • 1. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade.
    Giugliano D; Ceriello A; di Pinto P; Saccomanno F; Gentile S; Cappiapuoti F
    Diabetes; 1982 Apr; 31(4 Pt 1):367-70. PubMed ID: 6295856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxone on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1984 Jun; 102(1):135-9. PubMed ID: 6090153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release.
    Giugliano D; Di Pinto P; Ceriello A; Saccomanno F; Passariello N; D'Onofrio F
    Diabete Metab; 1985 Dec; 11(6):350-8. PubMed ID: 3936737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone on the insulin and GH responses to alpha-adrenergic stimulation with clonidine.
    Massara F; Limone P; Cagliero E; Tagliabue M; Isaia GC; Molinatti GM
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):371-5. PubMed ID: 6136141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
    el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired insulin secretion in human diabetes mellitus. II. A possible role for prostaglandins.
    Giugliano D; Sgamboto S; Coppola L; Misso L; Torella R
    Prostaglandins Med; 1981 Jan; 6(1):41-50. PubMed ID: 6784135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin responses to glucose in non-insulin-dependent diabetic subjects with and without the chlorpropamide-alcohol flush: effect of salicylate and naloxone.
    Hershon KS; Bierman EL; Bruzzone CM; Ensinck JW
    Diabetes Care; 1982; 5(4):404-8. PubMed ID: 6759079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endogenous opiate modulators of insulin secretion in the obese].
    Satta MA; Maussier ML; Scoppola A; Menini E; Liberale I; Lio S; Monaco F; Roche J
    C R Seances Soc Biol Fil; 1988; 182(6):538-43. PubMed ID: 2978011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate receptors and the metabolic response to intravenous glucose.
    Leslie RD; Eff C; Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Alberti KG
    Diabete Metab; 1982 Sep; 8(3):235-9. PubMed ID: 6292013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of insulin and glucagon secretion by opiates: a study with naloxone in healthy humans.
    Locatelli A; Spotti D; Caviezel F
    Acta Diabetol Lat; 1985; 22(1):25-31. PubMed ID: 3890450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
    Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
    Lerner RL; Porte D
    J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function.
    Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
    Regul Pept; 1983 Nov; 7(3):243-52. PubMed ID: 6141625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice.
    Bailey CJ; Flatt PR
    Diabetologia; 1987 Jan; 30(1):33-7. PubMed ID: 3032718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease.
    Lanzone A; Fulghesu AM; Fortini A; Cutillo G; Cucinelli F; Di Simone N; Caruso A; Mancuso S
    Hum Reprod; 1991 Sep; 6(8):1043-9. PubMed ID: 1666896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone-induced opiate receptors blockade on insulin secretion in obesity.
    Vettor R; Martini C; Manno M; Cestaro S; Federspil G; Sicolo N
    Horm Metab Res; 1985 Jul; 17(7):374-5. PubMed ID: 2993144
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion.
    Masotto C; Negro-Vilar A
    Endocrinology; 1988 Aug; 123(2):747-52. PubMed ID: 2840268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of naloxone and naltrexone on the postprandial energy expenditure and endocrine pancreas response to a mixed meal in essential obesity].
    Signorini AM; Fondelli C; Garosi G; Borgogni L; Tanganelli I; Gragnoli G
    Boll Soc Ital Biol Sper; 1993; 69(7-8):447-52. PubMed ID: 7908805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
    Goodner CJ; Conway MJ; Werbach JH
    J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.